Brief: Dermapharm Invests In Family-Owned Austrian Pharmaceutical Company Montavit
June 13 (Reuters) - Dermapharm Holding SE DMPG.DE :
* INVESTS IN FAMILY-OWNED AUSTRIAN PHARMACEUTICAL COMPANY
MONTAVIT
* CONTRACTUALLY ACQUIRED A SIGNIFICANT INTEREST IN
PHARMAZEUTISCHE
FABRIK MONTAVIT GESELLSCHAFT M.B.H. ("MONTAVIT"), ABSAM, TYROL,
AUSTRIA, VIA ITS WHOLLY OWNED SUBSIDIARY DERMAPHARM AG ON 7 JUNE
2023
Source text for Eikon: ID:nEQ4hsRtfa
Further company coverage: DMPG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Dermapharm Holding SE
See all newsBrief: Dermapharm Confirms 2026 Forecast
Corrected: Germany's Dermapharm prelim H1 revenue rises, maintains outlook
Brief: Dermapharm Holding - Confirms Full-Year Guidance For 2026
Brief: Dermapharm Spokesperson - Dermapharm Is Engaged In A Constructive Dialogue With The Regulator
Refile: BUZZ-Dermapharm Holding slips after BaFin's audit